Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antiproliferative agents disclosed by Kitasato Institute

Dec. 2, 1996

Novel porphycene compounds synthesized at Cytopharm

Dec. 2, 1996

DepoTech begins filing NDA for DepoCyt

Nov. 29, 1996

Anticancer compound from AEterna enters the clinic

Nov. 29, 1996

3DP seeks partners for potential treatments for retinopathies and cancer

Nov. 29, 1996

Novel nonmacrolide antitumor agent discovered by Mitsubishi

Nov. 29, 1996

New bombesin analogues from Biomeasure

Nov. 29, 1996

New market introduction for antiestrogen

Nov. 28, 1996

New 5-FU formulation reduces toxicity in mice

Nov. 28, 1996

Exclusive worldwide rights offered for human full-length TRK-B

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...